Continuous treatment with onabotulinumtoxinA for a mean of 9.1 years was associated with very high patient satisfaction.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: